"The strength of the associations of the biomarkers with higher risk of thunderstorm asthma and hospitalization in those with rhinitis was a surprise. In particular the threshold of allergen specific ...
Please provide your email address to receive an email when new articles are posted on . Patients with oral corticosteroid-dependent, severe eosinophilic asthma treated with benralizumab achieved ...
Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Following use of race-neutral lung function equations, African American and Latino pediatric ...
Researchers in Sweden conducted a real-world clinical study involving 123 participants (mean age, 33 years; 67% females) with asthma-like symptoms to evaluate the diagnostic accuracy of dynamic ...
Bronchi during asthma attack Dupilumab significantly reduced severe asthma exacerbations and improved prebronchodilator FEV1 in patients with baseline FeNO greater than or equal to 25 ppb with/without ...
A recent review article, "Clinical Tools to Assess Asthma Control in Children," [1] collates multiple subjective and objective measures that clinicians can use to determine whether a patient has ...
—Is it asthma? Is it chronic obstructive pulmonary disease? In a genome-wide association study, researchers in the U.K. have determined signals that are associated with both diseases. Here are the ...
asthma, lungs Authors review changes in the diagnosis, workup, and treatment of asthma in the 2022 GINA report. Some patients with asthma who lack evidence of type 2 inflammation are considered to ...
Tezspire (tezepelumab-ekko) is a monthly injection used to treat severe asthma. It was approved by the FDA in 2021 for use in addition to other asthma controlling medicines in people 12 and older.
Pulmonary function tests are a group of noninvasive breathing tests that measure how much air your lungs can hold, how quickly you can move air in and out and how efficiently your lungs transfer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results